HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Immunological profile of lymphoid cells in patients with chronic lymphoid leukemia and immunological complications during the treatment with prednisolone and chlorambucil].

Abstract
Comparative study of immunological phenotype of lymphoid cells of peripheral blood of patients with chronic lymphoid leukemia (CLL) and immune cytopenia at the treatment with prednisolone and chlorambucil has been carried out. It was shown, that inclusion in the treatment of chlorambucil (chlorambucil + prednisolone) enabled the achievement of remission of immune process at the majority of patients though average duration of remission essentially did not differ. The best clinical result was accompanied by more essential variations of leukemic B-cellular population than during the treatment with prednisolone alone. The reduction of absolute number of lymphocytes in patients with CLL under the treatment with chlorambucil and prednisolone was accompanied by reduction of expression of separate B-cellular antigens of mature cells with minimal signs of their activation. The expediency of a combination of prednisolone with chlorambucil in cases of high leukocytosis and expressed hyperplasia of organs of the limphoid systems.
AuthorsV O Lohins'kyĭ, Iu S Karol', O M Tsiapka, Ia I Vyhovs'ka
JournalLikars'ka sprava (Lik Sprava) 2009 Jan-Feb Issue 1-2 Pg. 44-9 ISSN: 1019-5297 [Print] Ukraine
PMID19953990 (Publication Type: Clinical Trial, English Abstract, Journal Article)
Chemical References
  • Antigens, CD
  • Chlorambucil
  • Prednisolone
Topics
  • Aged
  • Antigens, CD (biosynthesis, immunology)
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, therapeutic use)
  • Autoimmune Diseases (complications, drug therapy, immunology)
  • B-Lymphocytes (drug effects, immunology)
  • Cell Membrane (drug effects, immunology)
  • Chlorambucil (administration & dosage, therapeutic use)
  • Female
  • Humans
  • Immunophenotyping
  • Leukemia, Lymphocytic, Chronic, B-Cell (complications, drug therapy, immunology)
  • Male
  • Middle Aged
  • Prednisolone (administration & dosage, therapeutic use)
  • Remission Induction
  • T-Lymphocytes (drug effects, immunology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: